Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Interesting response from ETrade

Yes, I also took note of the "near future" comment and thought of it as significant as most of the other items dissected by others.

Activities that will increase shareholder confidence...

First thing that comes to mind is open market purchases and they cannot do that until april, unless you consider that in the near future. Obviously, activities could mean many things like M/A, impressive new bod nomination, investment in some other entity etc. What is important is that it appears,imo, to be activities outside of the normal licensing done by TPL/Alliacense. I would assume since they cannot purchase stock, that activities in the near future, also does not involve reducing ownership by S/L as well. It all depends on your interpretation of near, but it sounds encouraging to me.

Share
New Message
Please login to post a reply